 Connection
Mary Sammel to Misoprostol
This is a "connection" page, showing publications Mary Sammel has written about Misoprostol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.123 |
|
|
|
-
Schreiber CA, Ratcliffe SJ, Quinley KE, Miller C, Sammel MD. Serum biomarkers may help predict successful misoprostol management of early pregnancy failure. Reprod Biol. 2015 Jun; 15(2):79-85.
Score: 0.462
-
Roe AH, Abernathy A, Flynn AN, McAllister A, Koelper NC, Sammel MD, Schreiber CA, Sonalkar S. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss. Obstet Gynecol. 2022 06 01; 139(6):1149-1151.
Score: 0.191
-
Flynn AN, Roe AH, Koelper N, McAllister A, Sammel MD, Schreiber CA. Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss. Contraception. 2021 06; 103(6):404-407.
Score: 0.174
-
Sonalkar S, Koelper N, Creinin MD, Atrio JM, Sammel MD, McAllister A, Schreiber CA. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. Am J Obstet Gynecol. 2020 10; 223(4):551.e1-551.e7.
Score: 0.165
-
Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 12; 128(6):1357-1364.
Score: 0.131
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|